[1]
R. Zulfikar, “Deprescribing to Reduce Harm From Polypharmacy in Chronic Disease: What Works, for Whom, and at What Cost”, AIM, vol. 3, no. 4, Dec. 2025, doi: 10.59652/74hna989.